GPT and liver disorder: While a minority of patients present with high titer viremia and normal ALT in an apparent immune-tolerant (IT) phase, others can present in immune-active (IA) phase, with elevated ALT reflecting hepatocellular injury, followed by clinical resolution to an inactive phase or persistent disease with recurrent flares of ALT and viremia, as well as liver disease progression (4–6).